|
BPGM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.382200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.921200E-01 |
| Normal-vs-Stage2 |
8.810200E-01 |
| Normal-vs-Stage3 |
5.943900E-03 |
| Normal-vs-Stage4 |
9.143200E-01 |
| Stage1-vs-Stage2 |
9.842000E-01 |
| Stage1-vs-Stage3 |
1.032040E-02 |
| Stage1-vs-Stage4 |
9.923800E-01 |
| Stage2-vs-Stage3 |
1.396440E-01 |
| Stage2-vs-Stage4 |
9.834600E-01 |
| Stage3-vs-Stage4 |
1.218780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.390400E-01 |
| Normal-vs-AfricanAmerican |
3.087200E-01 |
| Normal-vs-Asian |
5.204800E-01 |
| Caucasian-vs-AfricanAmerican |
7.002200E-02 |
| Caucasian-vs-Asian |
3.030200E-01 |
| AfricanAmerican-vs-Asian |
7.189800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.818040E-01 |
| Normal-vs-Female |
4.352400E-01 |
| Male-vs-Female |
1.021560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.282000E-01 |
| Normal-vs-Extreme_Weight |
1.720450E-01 |
| Normal-vs-Obese |
6.254800E-01 |
| Normal-vs-Extreme_Obese |
4.152200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.839200E-01 |
| Normal_Weight-vs-Obese |
6.106200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.271000E-01 |
| Extreme_Weight-vs-Obese |
6.465400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.379400E-01 |
| Obese-vs-Extreme_Obese |
2.860000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.977600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.814000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.151600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.085800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.405400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.077800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.493570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.494760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.656400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.488600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.538800E-01 |
| Normal-VS-Type2 PRCC |
5.013900E-04 |
| Normal-VS-KIRP CIMP |
4.321400E-01 |
| Normal-VS-Unclassified PRCC |
6.878100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.78249999996483E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.215400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.483300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.524000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.480200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.646030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.230400E-01 |
| Normal-vs-N1 |
1.325810E-02 |
| Normal-vs-N2 |
5.156400E-01 |
| N0-vs-N1 |
2.948000E-01 |
| N0-vs-N2 |
4.076800E-01 |
| N1-vs-N2 |
1.283780E-01 |
|
|
